TRY FIRST: A 12-Week, randomized, open-label trial of duloxetine versus generic SSRIs in the treatment of a severe depressive episode.

Trial Profile

TRY FIRST: A 12-Week, randomized, open-label trial of duloxetine versus generic SSRIs in the treatment of a severe depressive episode.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2011

At a glance

  • Drugs Citalopram; Duloxetine; Fluoxetine; Paroxetine; Sertraline
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms TRY FIRST
  • Sponsors Eli Lilly
  • Most Recent Events

    • 24 Oct 2011 Primary endpoint 'Quick-Inventory-of-Depressive-Symptomology-Self-Report' has not been met.
    • 24 Oct 2011 Results published in the International Clinical Psychopharmacology.
    • 14 Jun 2010 Patient numbers amended from 759 to 750 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top